Quince Therapeutics (QNCX) Metrics: History & Chart

Quince Therapeutics, Inc.(QNCX)

Biotechnology · South San Francisco, CA

$27.11-0.99 (-3.52%)

Delayed quote: Oct 6, 2026, 1:59 PM EDT

About Quince Therapeutics, Inc.

Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.

South San Francisco, CA

38 employees

www.quincetx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Dirk Thye

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.10%
30D Total Return	-10.28%
YTD Total Return	-95.81%
1Y Total Return	-91.48%
3Y Total Return	-87.99%
5Y Total Return	-99.86%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-95.81%
2025	+79.14%
2024	+78.10%
2023	+64.84%
2022	-94.95%
2021	-54.57%
2020

CAGR TTM	-91.38%
CAGR 3Y	-50.66%
CAGR 5Y	-72.96%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

QNCX Valuation Metrics

QNCX Stock Price Metrics

QNCX Dividend Metrics

QNCX Growth Rate Metrics

QNCX Discounted Cash Flow Metrics

QNCX Returns By Period

QNCX Yearly Returns

QNCX Average Annual Returns By Period (CAGR)

QNCX Revenue Metrics

QNCX PE Ratio Metrics

QNCX PS Ratio Metrics

QNCX PB Ratio Metrics

QNCX Price to Free Cash Flow Ratio Metrics

QNCX Debt to Equity Ratio Metrics

QNCX PEG Ratio Metrics

QNCX FCF Yield

QNCX Earnings Yield

QNCX EBITDA Yield

QNCX OCF Yield

QNCX EV/EBIT Ratio Metrics

QNCX EV/EBITDA Ratio Metrics

QNCX EV/Assets Ratio Metrics

QNCX EV/Sales Ratio Metrics

QNCX Current Ratio Metrics

QNCX Quick Ratio Metrics

QNCX ROIC Metrics

QNCX Return on Assets Metrics

QNCX Return on Equity Metrics

QNCX Net Profit Margin Metrics

QNCX Gross Profit Margin Metrics

QNCX Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	0.54
PB Ratio Avg TTM	4.31
PB Ratio Avg 3Y	1.94
Current VS TTM Avg	-87.48%
Current VS 3Y Avg	-72.10%
Current VS 5Y Avg	-51.04%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	3.60
Debt/Equity Ratio Avg 3Y	0.17
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.45
Ev/Assets Ratio Avg TTM	0.75
Ev/Assets Ratio Avg 3Y	0.42
Current VS TTM Avg	-39.78%
Current VS 3Y Avg	+8.26%
Current VS 5Y Avg	+23.61%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	14.52
Current Ratio Avg TTM	4.82
Current Ratio Avg 3Y	5.92
Current VS TTM Avg	+201.36%
Current VS 3Y Avg	+145.26%
Current VS 5Y Avg	+41.12%

Quick Ratio	14.52
Quick Ratio Avg TTM	4.82
Quick Ratio Avg 3Y	5.92
Current VS TTM Avg	+201.36%
Current VS 3Y Avg	+145.26%
Current VS 5Y Avg	+41.12%

ROIC	(107.08%)
ROIC Avg 3Y	(43.89%)
ROIC Avg 5Y	(55.83%)
Current VS 3Y Avg	-144.00%
Current VS 5Y Avg	-91.82%
Current VS 10Y Avg	-126.18%

ROA	(74.58%)
ROA Avg TTM	1.18%
ROA Avg 3Y	(9.94%)
Current VS TTM Avg	-6424.02%
Current VS 3Y Avg	-649.93%
Current VS 5Y Avg	-559.42%

ROE	(85.24%)
ROE Avg TTM	(237.94%)
ROE Avg 3Y	(146.12%)
Current VS TTM Avg	+64.18%
Current VS 3Y Avg	+41.66%
Current VS 5Y Avg	-4.39%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	(17.46%)
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A